Nebivolol (Bystolic®), a novel, highly cardioselective, third-generation β-blocker that recently received approval by the US FDA for the treatment of hypertension in the USA, is effective in ...

Clinical trials have compared nebivolol at target dosages of 5 and 10 mg once daily with placebo and, in small trials, with carvedilol in the treatment of adults with chronic heart failure.

Nebivolol is the generic form of the hypertension ... prescription only in 30-count bottles of tablets in 2.5-milligram (mg) doses. Consumers can identify the affected products using information ...

Discover all the brand names or Trade names of generic drug called Nebivolol. This serves as a crucial reference for healthcare professionals, patients, caregivers, and anyone looking to ...